|
1
|
Nakagawa-Senda H, Hori M, Matsuda T and
Ito H: Prognostic impact of tumor location in colon cancer: The
Monitoring of Cancer Incidence in Japan (MCIJ) project. BMC Cancer.
19:4312019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu J, Dong H, Zhang Q and Zhang S:
Combined assays for serum carcinoembryonic antigen and
microRNA-17-3p offer improved diagnostic potential for stage I/II
colon cancer. Mol Clin Oncol. 3:1315–1318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paudel MS, Mandal AK, Shrestha B, Poudyal
NS, Kc S, Chaudhary S, Shrestha R and Goel K: Prevalence of organic
colonic lesions by colonoscopy in patients fulfilling ROME IV
criteria of irritable bowel syndrome. JNMA J Nepal Med Assoc.
56:487–492. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mayanagi S, Kashiwabara K, Honda M, Oba K,
Aoyama T, Kanda M, Maeda H, Hamada C, Sadahiro S, Sakamoto J, et
al: Risk factors for peritoneal recurrence in stage II to III colon
cancer. Dis Colon Rectum. 61:803–808. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Q, Zhang C, Ma JX, Ren H, Sun Y and
Xu JZ: Circular RNA PIP5K1A promotes colon cancer development
through inhibiting miR-1273a. World J Gastroenterol. 25:5300–5309.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brase JC, Wuttig D, Kuner R and Sültmann
H: Serum microRNAs as non-invasive biomarkers for cancer. Mol
Cancer. 9:3062010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zeng M, Zhu L, Li L and Kang C: miR-378
suppresses the proliferation, migration and invasion of colon
cancer cells by inhibiting SDAD1. Cell Mol Biol Lett. 22:122017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sheng S, Xie L, Wu Y, Ding M, Zhang T and
Wang X: MiR-144 inhibits growth and metastasis in colon cancer by
down-regulating SMAD4. Biosci Rep. 39:BSR201818952019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang W, Sun Z, Su L, Wang F, Jiang Y, Yu
D, Zhang F, Sun Z and Liang W: miRNA-185 serves as a prognostic
factor and suppresses migration and invasion through Wnt1 in colon
cancer. Eur J Pharmacol. 825:75–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chai B, Guo Y, Cui X, Liu J, Suo Y, Dou Z
and Li N: MiR-223-3p promotes the proliferation, invasion and
migration of colon cancer cells by negative regulating PRDM1. Am J
Transl Res. 11:4516–4523. 2019.PubMed/NCBI
|
|
11
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hagman Z, Haflidadottir BS, Ansari M,
Persson M, Bjartell A, Edsjö A and Ceder Y: The tumour suppressor
miR-34c targets MET in prostate cancer cells. Br J Cancer.
109:1271–1278. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roy S, Levi E, Majumdar AP and Sarkar FH:
Expression of miR-34 is lost in colon cancer which can be
re-expressed by a novel agent CDF. J Hematol Oncol. 5:582012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang Z, Li X, Liu S, Li C, Wang X and
Xing J: MiR-141-3p inhibits cell proliferation, migration and
invasion by targeting TRAF5 in colorectal cancer. Biochem Biophys
Res Commun. 514:699–705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wan Y, Shen A, Qi F, Chu J, Cai Q, Sferra
TJ, Peng J and Chen Y: Pien Tze Huang inhibits the proliferation of
colorectal cancer cells by increasing the expression of miR-34c-5p.
Exp Ther Med. 14:3901–3907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benson AB III, Venook AP, Cederquist L,
Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC,
Fichera A, et al: Colon cancer, version 1.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schweiger MR, Hussong M, Röhr C and
Lehrach H: Genomics and epigenomics of colorectal cancer. Wiley
Interdiscip Rev Syst Biol Med. 5:205–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soler M, Estevez MC, Villar-Vazquez R,
Casal JI and Lechuga LM: Label-free nanoplasmonic sensing of
tumor-associate autoantibodies for early diagnosis of colorectal
cancer. Anal Chim Act. 930:31–38. 2016. View Article : Google Scholar
|
|
19
|
Arnarson Ö, Butt-Tuna S and Syk I:
Postoperative complication following colonic resection for cancer
is associated with impaired long-term survival. Colorectal Dis.
21:805–815. 2019.PubMed/NCBI
|
|
20
|
Baxter NN, Goldwasser MA, Paszat LF,
Saskin R, Urbach DR and Rabeneck L: Association of colonoscopy and
death from colorectal cancer. Ann Intern Med. 150:1–8. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lieberman DA, Weiss DG, Bond JH, Ahnen DJ,
Garewal H and Chejfec G: Use of colonoscopy to screen asymptomatic
adults for colorectal cancer. N Engl J Med. 343:162–168. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burt RW: Colon cancer screening.
Gastroenterology. 119:837–853. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahmed FE, Ahmed NC, Gouda M and Vos P:
MiRNAs for the diagnostic screening of early stages of colon cancer
in stool or blood. Surg Case Rep Rev. 1:1–19. 2017. View Article : Google Scholar
|
|
24
|
Baffa R, Fassan M, Volinia S, O'Hara B,
Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM and
Rosenberg A: MicroRNA expression profiling of human metastatic
cancers identifies cancer gene targets. J Pathol. 219:214–221.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Osaki M, Okada F and Ochiya T: miRNA
therapy targeting cancer stem cells: A new paradigm for cancer
treatment and prevention of tumor recurrence. Ther Deliv.
6:323–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng L, Ma H, Chang L, Zhou X, Wang N,
Zhao L, Zuo J, Wang Y, Han J and Wang G: Role of microRNA-141 in
colorectal cancer with lymph node metastasis. Exp Ther Med.
12:3405–3410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li F, Chen H, Huang Y, Zhang Q, Xue J, Liu
Z and Zheng F: miR-34c plays a role of tumor suppressor in HEC-1-B
cells by targeting E2F3 protein. Oncol Rep. 33:3069–3074. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang S, Li W, Sun H, Wu B, Ji F, Sun T,
Chang H, Shen P, Wang Y and Zhou D: Resveratrol elicits
anti-colorectal cancer effect by activating miR-34c-KITLG in vitro
and in vivo. BMC Cancer. 15:9692015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao Y, Feng B, Han S, Zhang K, Chen J, Li
C, Wang R and Chen L: The roles of MicroRNA-141 in human cancers:
From diagnosis to treatment. Cell Physiol Biochem. 38:427–448.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tao F, Tian X, Lu M and Zhang Z: A novel
lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and
migration by sponging miR-34a and miR-34c. J Genet Genomics.
45:137–145. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Wang G, Li B, Qiu C and He M:
miR-141-3p is a key negative regulator of the EGFR pathway in
osteosarcoma. Onco Targets Ther. 11:44612018. View Article : Google Scholar : PubMed/NCBI
|
